SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-010844
Filing Date
2018-05-04
Accepted
2018-05-04 07:54:13
Documents
51
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acad-10q_20180331.htm 10-Q 1246260
2 EX-10.1 acad-ex101_184.htm EX-10.1 3592
3 EX-31.1 acad-ex311_9.htm EX-31.1 9491
4 EX-31.2 acad-ex312_7.htm EX-31.2 9219
5 EX-32.1 acad-ex321_8.htm EX-32.1 6358
6 EX-32.2 acad-ex322_6.htm EX-32.2 6389
  Complete submission text file 0001564590-18-010844.txt   3995720

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acad-20180331.xml EX-101.INS 797824
8 XBRL TAXONOMY EXTENSION SCHEMA acad-20180331.xsd EX-101.SCH 28437
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20180331_cal.xml EX-101.CAL 41522
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20180331_def.xml EX-101.DEF 66087
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20180331_lab.xml EX-101.LAB 216352
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20180331_pre.xml EX-101.PRE 159892
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 18806050
SIC: 2834 Pharmaceutical Preparations